Skip to main content

An actualized screening of schizophrenia-associated genes



Schizophrenia is a psychotic disorder that impacts around 0.5% to 1.2% of the world's population. It has been well established that heredity plays an essential role in the causation of schizophrenia, with genetic heritability of up to 80%. A several new schizophrenia susceptibility genes were identified at the start of the twenty-first century. The aim of this systematic review will be to explore the association between single nucleotide polymorphisms (SNPs) and schizophrenia risk in people all over the world.


This systematic review collected available data on genetic variants associated with schizophrenia in worldwide populations. A PubMed and Science Direct search was investigated to identify all studies published until December 2020 on genetic susceptibility to schizophrenia in various populations, excluding family studies, transversal studies, cohort studies, experimental studies, and descriptive studies; those that demonstrate an association between repeat polymorphism (CNV, VNTR, etc.). All researches on genetic predispositions of schizophrenia and accepting the predetermined inclusion criteria were included in this systematic review.


Thirty-six studies focused on the schizophrenia-associated genes were retained in which a total of 44 polymorphisms among 26 susceptibility genes to schizophrenia have been associated in the world populations.


Despite the few number of studies published about genetic of schizophrenia, some genetic variations have been consistently correlated to schizophrenia, particularly in China, as this analysis shows. Further data, especially from genome-wide association studies, might contribute in the development of a reference for schizophrenia genetic susceptibility markers.


Schizophrenia is conceptualized as a psychotic disorder according to DSM-5. Delusions, hallucinations, and disordered speech are basic "positive symptoms" that may be reliably identified with schizophrenia and may be regarded crucial for a successful diagnosis [1]. With an early onset in late adolescence or early adulthood, the disease affects about 0.5% to 1.2% of the global population. The most common clinical manifestations are positive symptoms, particularly hallucinations and delusions, on the one hand, and negative symptoms, such as reduced mood, speech and interest, as well as language and behavioral disorders, on the other hand [2].

It has been well established that heredity plays a significant role in the causation of schizophrenia, with genetic heritability of up to 80% [3]. Evidence in this context is available from family studies, genetic associations, and genetic linkage studies. Despite the high heritability, the genetic susceptibility factors that contribute to this disease have not been fully elucidated [4].

The scientific community has long sought to understand the pathogenesis of schizophrenia; however, due to high disease's complexity, this objective has proven difficult to achieve. Researchers have browsed the entire human genome for loci and genetic alterations (e.g., single nucleotide polymorphisms [SNPs]) that may be related to schizophrenia and other psychiatric disorders over the last decade [5].

A number of new schizophrenia susceptibility genes were identified at the start of the twenty-first century, and to this day more than 1000 genes have been analyzed for their potential association with schizophrenia. These genes were discovered through association studies based on their chromosomal position or their function. Among the genes that have been suggested to converge functionally on schizophrenia risk, we highlight ACE, GRM3, GSTs, DTNBP1, EFHD2, ERBB4, GABRB2…[5].

A recent systematic review and meta-analysis indicated that AMBRA1, ANK3, ARNTL, CDH13, EFHD1, MHC, PLXNA2, and UGT1A1 were revealed to be linked with SCZ or bipolar disorder (BD) diagnosis in at least two independent samples [6].

Similar to other psychiatric diseases, schizophrenia arises from an interplay between genetic and environmental factors. Studies in Chinese, Spanish, Indian, Iranian, Caucasian, and other populations around the world have shown robust genetic predispositions to this disease. This systematic review aims to collect available information on the genetic determinants of schizophrenia, more precisely to explore the association between single nucleotide polymorphisms (SNPs) and schizophrenia risk in people all over the world.

Methods used for systematic review

This systematic review was reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. This article will discuss the epidemiology and genetics of schizophrenia in the global population. This is a systematic review based on publicly available data. As a result, no ethical approval is needed.

Bibliographic search

We searched Medline through PubMed and Science Direct databases for all existing genome-wide associations studies (GWAS) of schizophrenia that has been published in English from database inception until December 2020. Additionally, the reference lists of pertinent articles and reviews were checked for further articles.

Selection of studies

We included observational studies, particularly cases–control studies that assessed the link between genetic polymorphisms and schizophrenia in various populations.

To focus on genetic as a complex trait of schizophrenia we excluded (1) family studies, transversal studies, cohort studies, experimental studies and descriptive studies; (2) those that demonstrate an association between repeat polymorphism (CNV, VNTR, etc.), mutations and schizophrenia.

For studies reported in several reports, we considered the most detailed reporting on the largest sample size. Three authors (H.B., F.G., and A.H.O.) individually examined articles for inclusion (titles, abstracts, and then full texts).

Data extraction, assessment, and synthesis

Three investigators (H.B., F.G., and A.H.O.) extracted data from qualified articles using an essentialist data extraction form. The gathered information contained the country of the study, study population, sample size, mean age, range and proportion of men for cases and controls, genotyping method, gene and polymorphism studied, and the outcome (effects of studied polymorphism on the disease).

Due to high heterogeneity among included studies, the impact of a genetic variant on schizophrenia (their association, or none association) was identified as linked (YES) or unlinked (NO) based on whether the polymorphism was associated or not with a risk of schizophrenia.

A fourth experienced investigator double-checked all collected evidence for consistency (Hm.B.).

Our decision to conduct a narrative synthesis of the collected data is informed by the small number of qualifying studies and the enormous variation between research pertaining to sample population characteristics and evaluation of the association of genetic polymorphisms and schizophrenia.

Results of the systematic review

Literature search

Our initial database search identified 5804 records from PubMed (n = 1632) and Science Direct (n = 4173); after removal of duplicates (n = 352), 5452 records remained. Since checking titles and abstracts, we identified 5220 records to be irrelevant and excluded them. We examined the complete texts of the remaining 232 articles to see if they were appropriate, of which 36 were eventually added [7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42] and 196 were excluded with reasons as indicated in Fig. 1.

Fig. 1
figure 1

Preferred reporting items for the systematic reviews and meta-analysis (PRISMA)

Populations, genetic evaluation, and results

Of the 36 studies analyzed, 25 articles enrolled patients with schizophrenia of Asian origin (69,44%) [7,8,9,10, 12, 13, 15,16,17,18,19,20, 22,23,24,25, 28, 29, 33, 36,37,38,39,40, 42]. Patients of European ancestry were included in 6 articles (16,66%) [11, 26, 27, 30, 32, 41], whereas only 2 of African origin (5,55%) [21, 35], and the self-reported ethnic background in the last 3 article is African, African-American, Asian, and European [14, 31, 34]. All studies have been carried out on patients who had schizophrenia. Participants ranged in age from 16 to 76 years, with a men ratio ranging from 46 to 100% based on the population. Across studies, a total of 121 polymorphisms (including single nucleotide polymorphisms (SNPs) and insertion/deletions among 39 different genes were investigated (Table 1).

Table 1 The different genes investigated within the selected articles

All SNPs in the selected studies fall in multifunctional scaffold proteins that are expressed in neurons and interact with multiple proteins involved in neuronal migration, glutamatergic, neurotransmission, signal transduction, and hippocampal development, all of which are implicated in the etiology of schizophrenia [15]. Indels were located primarily in the angiotensin converting enzyme (ACE), NQO2, and PAI-1 genes. The aim of all of the researches was to see whether there was a correlation between genetic determinants and schizophrenia in general populations.

Schizophrenia-associated genes

We identified 26 genes and 44 significant genetic polymorphisms implicated in schizophrenia in the research included in this review. Four studies about the 26 genes showing an association with schizophrenia were conducted in the Chinese population DISC1 (rs821616, rs821597), GLRX5 (rs1007814), NRG1 (rs3924999), TCF4 (rs2958182) [18, 20, 40]. Four other studies in Chinese Han population C3 (Complement 3) polymorphism (rs11569514), CACNA2D2 (rs45536634), four polymorphisms of NRXN1 (rs10490168, rs2 024513, rs13382584, rs1558852), and two polymorphisms of OPRM1 (rs1799971. rs2075572) [13, 16, 37, 42]. In the Korean population, a similar associations were detected with GRIA1 (rs1428920, rs2926835), TLR2 (rs3804099, rs3804100), HDAC3 (rs2530223) HDAC4 (rs1063639), DTNBP1 (rs760761, rs2619522) [23,24,25, 33]. Three other studies analyzed previously shown to be associated with schizophrenia in the northern and northeast Chinese han population EFHD2 (rs2473357) [8, 10, 28]. Studies in Iranian population showed that the II genotype of the I/D polymorphism of ACE gene, (rs1816072 (T/C)) polymorphism of GABRB2 and the (Haplotype Val-Lys) of XPC gene have a significant association with the susceptibility of schizophrenia [19, 29, 38].

It has already been found that there is a correlation between (GSTT1) polymorphism of GSTs, and Q64R (Gln64Arg) polymorphism of IFNGR2 and the risk of this disease in the Tunisian population [21, 35]. Similar results were observed in Turkish with AUTS2 (rs6943555) [32], Taiwanese with DAOA (rs778292, rs3918342, rs1421292) [12], Pakistanian with DISC (rs1417584) [15], Jordanian with ERBB4 (rs839523) (G/A) [7], and Japanese population with NQO2 (Deletion) [17] gene polymorphisms, respectively (Table 2).

Table 2 The genetic polymorphisms implicated in schizophrenia included in this review

One study conducted in mixed ethnic sample (Caucasian and African-American population) demonstrated an association between schizophrenia [14] and polymorphisms in PDE4B (rs1354064, rs4320761, rs1040716, rs910694, rs1321177, rs2144719, rs783038, rs599381) (Table 2).

Studies with lack of association

Twelve studies from various population did not find a significant association with schizophrenia [9, 11, 12, 22, 26, 27, 30, 31, 34, 36, 39] (Table 2).


In this research, we used a systematic review to evaluate the correlation between polymorphisms and schizophrenia in the global population by integrating data from all qualifying studies. These powerful studies serve as informative summaries of the field's progress. Furthermore, a systematic review of smaller research will theoretically help entice and plan pathophysiological hypotheses for further genomic, transcriptomics, proteomics, and drug studies, particularly in unique populations. They can cover the research community's reflection on the diversity and discrepancies in samples, approaches, and conclusions through schizophrenia association, as well as make sense of current and prospective meta- and mega-analysis studies.

Our analysis showed that 75% of the overall pooled polymorphisms of these genes are SNPs (AUTS2, C3, CACNA2D2, DAO, DAOA, DISC, DISC1, DRD2, DTNBP1, EFHD2, ERBB4, GABRB2, GRLX5, GRIA1, GRIK4, HDAC, HSPA1A, HSPA1B, HSPA1L, NRG1, NRXN1, OPRM1, PDE4B, RANBP9, RELN, SAT-1, TCF4, TLR2, VEGFA, VRK2) and 25% of the others types of polymorphisms (ACE, GRM3, GSTs, IFNGR2, MTHFR, NQO2, PAI-1, PPARα, XPC).

After examining several articles across various populations, we selected 25 articles from the Asian population including 21 studies which found a significative association between polymorphism and schizophrenia, and four studies who failed to find an association. There are also 11 other studies from Europe, Africa, and the USA (2 African, 6 European, and 3 mixed African-American-European) among which 5 have found a relation between polymorphism and schizophrenia.

The Iranian study [29] investigated the role of the genotypes of I/D ACE polymorphism by PCR method. The deletion allele (D) was seen as a 191 bp band, whereas the insertion allele (I) was identified as a 478 bp band [29]. When compared to the DD genotype, the II genotype substantially reduced the risk of schizophrenia in females [29]. There was a strong linear relationship between the number of I alleles and the risk of schizophrenia in females. The sexes and the II genotype had a strong interaction [29]. The association between the ACE I/D polymorphism and the risk of schizophrenia has already been established. Two recent studies found contradictory results: the I allele was shown to be a protective factor in a Turkish population [43], although the D allele was found to be protective against schizophrenia and bipolar disorder in a Spanish population [44].

The study of C3 polymorphisms is still a major field in schizophrenia research. Association between the SNP rs11569514 in C3 and schizophrenia was investigated in Han Chinese population [37]. Interestingly, in the codominant model (TT vs. AA) the authors found a significant risk effect for rs11569514 on schizophrenia. Recent findings in the Tunisian population, as well as in the Brazilian population, show a significantly higher level of C3 protein in schizophrenia patients [45, 46].

In the research of Zhang et al. [39] among the northern Chinese Han population, there was no significant association between the (rs7116768) and (rs1799732) polymorphisms of the dopamine D2 receptor (DRD2) gene promoter region and schizophrenia [39], these results are consistent with those of previous research in a Spanish population [47], but are in contrast to the results in Brazilian population who found a significant association [48]. However, there are still some uncertainties concerning these associations.

The GRM3 gene was not associated with schizophrenia in the European and American populations [31]. Similar results were observed in the Japanese population [49]. However, other studies have instead reported a link between GRM3 genetic variation and risk of schizophrenia [50, 51].

Among single population studies, 12 variants of NQO2 gene were identified in Japanese population [17] including the insertion/deletion (I/D) polymorphism of the 29 base pair nucleotide sequence in the promoter region. In the schizophrenia group, the frequency of the D allele was significantly higher than in the healthy controls. The current findings show that individuals with the deletion of the 29 bp sequence in the promoter region of the NQO2 gene might be vulnerable to a specific type of schizophrenia [17]. Further research is needed on the implication of this polymorphism on schizophrenia.

One of the most promising potential genes for schizophrenia is neuregulin 1 (NRG1); the rs3924999 G/G genotype was associated with schizophrenia in the early onset subgroup (25 years) in the Chinese population [18]. Similar findings have been reported in Han Chinese and Japanese populations, where the NRG1 gene appears to contribute to schizophrenia susceptibility [52, 53].

In this research [14], 27 single nucleotide polymorphisms (SNPs) across the PDE4B gene were genotyped; several of these SNPs genotyped in the Caucasian population were substantially associated with schizophrenia. Two related intronic SNPs, rs1321177 and rs2144719, were particularly correlated to schizophrenia [14].

Although a number of studies have shown an association between the phosphodiesterase 4B (PDE4B) gene and the risk of schizophrenia, the findings are still inconclusive [54].

Reelin (RELN) is a protein involved in brain development and function and has been related to a variety of neuropsychiatric disorders. Bai et al. reported that the rs362746 of the RELN gene was associated with schizophrenia under the recessive and codominant models, in the Chinese population [10]. In Australia and Turkey, there was also a high correlation between this polymorphism and schizophrenia [55, 56].

The transcription factor 4 (TCF4) gene is highly expressed and plays a critical role in nervous system development, and it has long been implicated in the risk of developing schizophrenia [57].

The rs2958182 on TCF4 gene showed a significant association with schizophrenia in a meta-analysis in Chinese population [20]. This conclusion is in agreement with previous studies, in different ethnicities like Malaysians population, and Han Chinese population [57, 58].

VRK2 is a serine/threonine protein kinase enzyme encoded by the VRK2 gene on human chromosome 2p16.1. The VRK2 rs3732136 polymorphism was shown to be substantially linked with schizophrenia in the study of Zhang et al. [8] in a Northwest Chinese Han population, similar results were reported in other genotype and haplotype association studies. The results suggest that the VRK2 gene may play an important role in the development of schizophrenia in the Han population of northwest China [8]. The polymorphisms of serine/threonine-protein kinase (VRK2) were correlated to schizophrenia in two recent studies performed in Northern European and Asian populations [59, 60].

Several other polymorphisms were genotyped in different populations; for example, AUTS2 (rs6943555) [32], CACNA2D2 (rs45536634) [16], DAOA (rs778292, rs3918342, rs1421292) [12], DISC (rs1417584) [15], DISC1 (rs821616) [18], DNTBP1 (rs3213207, rs1011313, rs760761, and rs2619522) [33], EFHD2 (rs2473357) [28], ERBB4 (rs839523) [7], GABRB2 (rs12187676) [19], GLRX5 (rs1007814) [40], GRIA1 (rs1428920, rs2926835) [23], GSTs (GSTT1) [35], HDAC (rs1063639) [25], IFNGR2 (Q64R) [21], NRXN1 (rs10490168, rs2024513, rs13382584, rs1558852) [42], OPRM1 (rs1799971, rs2075572) [13], TLR2 (rs3804099) [24] and XPC [38] each found a significant association with schizophrenia.

In contrast some studies which genotyped other polymorphisms in several genes, for example, DAO [12], GRIK4 [36], HSPA1A [26] HSPA1B [27], HSPA1L [26], MTHFR [34], PAI-1 [41], PPARα [30], RANBP9 [9], SAT-1 [11], VEGFA [22], found no significant association with schizophrenia.

To fully understand the correlation between these polymorphisms and schizophrenia, further research with larger populations and prospective approaches is needed. Therefore, this systematic review still reveals new data of the impact of genes in schizophrenia risk.

A rigorous and systematic literature review, as well as the inclusion of multiple potential genetic risk factors for schizophrenia, is among the review's strengths. As many sample sizes were small, it is possible that the sample sizes were insufficient to detect a true association, especially because schizophrenia is most likely polygenic and influenced by many variants with small effect sizes.


Despite the few number of studies published about genetic of schizophrenia, some genetic variations have been consistently correlated to schizophrenia, particularly in China, as this analysis shows. Further data, especially from genome-wide association studies, might contribute in the development of a reference for schizophrenia genetic susceptibility markers.

Availability of data and materials

All data generated or analyzed during this study are included in this published article.



Polymorphism in angiotensin-converting enzyme


Autophagy and beclin 1 regulator 1


Ankyrin 13


Aryl hydrocarbon receptor nuclear translocator-like


Autism susceptibility gene 2 protein


Bipolar disorder


Complement 3


Calcium voltage-gated auxiliary subunit alpha 2 delta 2




D-amino acid oxidase.


D-amino acid oxidase activation.


Disrupted in schizophrenia


Disrupted in schizophrenia 1


Deoxyribonucleic acid


Dopamine receptor D2

DSM 5:

Diagnostic and statistical manual of fifth edition


Dystrobrevin-binding protein 1


EF-hand domain family member D1


EF-hand domain family member D2


Erb-b2 receptor tyrosine kinase 4


Gamma-aminobutyric acid type A receptor subunit beta 2


Glutaredoxin 5


Glutamate ionotropic receptor AMPA type subunit 1


Glutamate ionotropic kainite receptor 4


Glutamate metabotropic receptor 3


The glutathione S-transferase


Genome-wide association study


Histone deacetylase 3


Heat shock protein family A (Hsp70) member 1A


Heat shock protein family A (Hsp70) member 1B


Heat shock protein family A (Hsp70) member 1-like


Interferon gamma receptor 2




The major histocompatibility complex


Methylenetetrahydrofolate reductase


N-Ribosyldihydronicotinamide:quinone reductase 2


Neuregulin 1


Neurexin 1


µ-Opioid receptor gene


Odds ratio


P value


Plasminogen activator inhibitor-1


Phosphodiesterase 4B


Plexin A2


Peroxisome proliferator activated receptor alpha


Preferred reporting items for the systematic reviews and meta-analysis


Journal database


Ran-binding protein 9


Reelin is a protein coding gene


Spermidine/spermine N-1 acetyltransférase




Single nucleotide polymorphisms


Transcription factor 4


Toll-like receptor 2


UDP glucuronosyltransferase family 1 member A1


Vascular endothelial growth factor A


Variable number tandem repeat


Vaccinia-related kinase 2


Xeroderma pigmentosum, complementation group C


  1. Tandon R et al (2013) Definition and description of schizophrenia in the DSM-5. Schizophr Res 150:3–10

    Article  PubMed  Google Scholar 

  2. Jin L et al (2019) The association between rs12807809 polymorphism in neurogranin gene and risk of schizophrenia: a meta-analysis. Med (United States) 98:1–9

    CAS  Google Scholar 

  3. Sullivan PF, Kendler KS, Neale MC (2003) Schizophrenia as a complex trait. Arch Gen Psychiatry 60:1187

    Article  PubMed  Google Scholar 

  4. Kaur G et al (2019) An association study of dopaminergic (DRD2) and serotoninergic (5-HT2) gene polymorphism and schizophrenia in a North Indian population. Asian J Psychiatr 39:178–184

    Article  PubMed  Google Scholar 

  5. Zhuo C et al (2019) The genomics of schizophrenia: Shortcomings and solutions. Prog Neuro-Psychopharmacology Biol Psychiatry 93:71–76

    Article  CAS  Google Scholar 

  6. Prata DP, Costa-Neves B, Cosme G, Vassos E (2019) Unravelling the genetic basis of schizophrenia and bipolar disorder with GWAS: A systematic review. J Psychiatr Res 114:178–207

    Article  PubMed  Google Scholar 

  7. Al-Eitan L, Al-Habahbeh S, Alkhatib R (2017) Genetic association analysis of ERBB4 polymorphisms with the risk of schizophrenia susceptibility in a Jordanian population of Arab descent. Turk J Med Sci 47:542–553

    Article  CAS  PubMed  Google Scholar 

  8. Zhang B et al (2015) Association of the VRK2 gene rs3732136 polymorphism with schizophrenia in a Northwest Chinese Han population. Genet Mol Res 14:9404–9411

    Article  CAS  PubMed  Google Scholar 

  9. Bae JS et al (2015) Investigating the potential genetic association between RANBP9 polymorphisms and the risk of schizophrenia. Mol Med Rep 11:2975–2980

    Article  CAS  PubMed  Google Scholar 

  10. Bai W et al (2019) Association between RELN polymorphisms and schizophrenia in a Han population from Northeast China. Psychiatr Genet 29:232–236

    Article  CAS  PubMed  Google Scholar 

  11. Bermudo-Soriano CR et al (2009) SAT-1 -1415T/C polymorphism and susceptibility to schizophrenia. Prog Neuro-Psychopharmacology Biol Psychiatry 33:345–348

    Article  CAS  Google Scholar 

  12. Chu CS et al (2017) The DAOA gene is associated with schizophrenia in the Taiwanese population. Psychiatry Res 252:201–207

    Article  CAS  PubMed  Google Scholar 

  13. Ding S et al (2013) Association study of OPRM1 polymorphisms with Schizophrenia in Han Chinese population. BMC Psychiatry 13:107

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Fatemi SH et al (2008) PDE4B polymorphisms and decreased PDE4B expression are associated with schizophrenia. Schizophr Res 101:36–49

    Article  PubMed  Google Scholar 

  15. Fatima W et al (2020) Chromosomal region 1q24.1 is associated with increased risk of schizophrenia in Pakistani population. Gene 734:144390

    Article  CAS  PubMed  Google Scholar 

  16. Fu Y et al (2020) Association of the CACNA2D2 gene with schizophrenia in Chinese Han population. PeerJ 2020:1–11

    Google Scholar 

  17. Harada S, Tachikawa H, Kawanishi Y (2003) A possible association between an insertion/deletion polymorphism of the NQO2 gene and schizophrenia. Psychiatr Genet 13:205–209

    Article  PubMed  Google Scholar 

  18. He BS et al (2016) Association of the DISC1 and NRG1 genetic polymorphisms with schizophrenia in a Chinese population. Gene 590:293–297

    Article  CAS  PubMed  Google Scholar 

  19. Heidari Nia M, Sargazi S, Saravani R, Mirinejad S, Jahantigh D, Shakiba M (2020) Relationship between GABRB2 gene polymorphisms and schizophrenia susceptibility: a case-control study and in silico analyses. Int J Neurosci.

    Article  PubMed  Google Scholar 

  20. Gao JY, Ma P, Li Y, Yan CX, Zhang Q, Yang XX, Shi Q, Zhang B, Wen XP (2020) Association between a TCF4 Polymorphism and Susceptibility to Schizophrenia. Biomed Res Int. 2020:1216303.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Jemli A et al (2017) IFNGR2 genetic polymorphism associated with sex-specific paranoid schizophrenia risk. Nord J Psychiatry 71:42–47

    Article  PubMed  Google Scholar 

  22. Gao K et al (2015) Association study of VEGFA polymorphisms with schizophrenia in Han Chinese population. Neurosci Lett 590:121–125

    Article  CAS  PubMed  Google Scholar 

  23. Kang WS et al (2012) Genetic variants of GRIA1 are associated with susceptibility to schizophrenia in Korean population. Mol Biol Rep 39:10697–10703

    Article  CAS  PubMed  Google Scholar 

  24. Kang WS et al (2013) Association between genetic polymorphisms of Toll-like receptor 2 (TLR2) and schizophrenia in the Korean population. Gene 526:182–186

    Article  CAS  PubMed  Google Scholar 

  25. Kim T, Park JK, Kim HJ, Chung JH, Kim JW (2010) Association of histone deacetylase genes with schizophrenia in Korean population. Psychiatry Res 178:266–269

    Article  CAS  PubMed  Google Scholar 

  26. Kowalczyk M et al (2018) Association studies of HSPA1A and HSPA1L gene polymorphisms with schizophrenia. Arch Med Res 49:342–349

    Article  CAS  PubMed  Google Scholar 

  27. Kowalczyk M et al (2020) Association of HSPA1B polymorphisms with paranoid schizophrenia in a polish population. NeuroMol Med 22:159–169

    Article  CAS  Google Scholar 

  28. Gao M et al (2020) Association between EFHD2 gene polymorphisms and schizophrenia among the Han population in northern China. J Int Med Res 48:10

    Google Scholar 

  29. Mazaheri H, Saadat M (2015) Association between insertion/deletion polymorphism in angio-tension converting enzyme and susceptibility to schizophrenia. Iran J Public Health 44:369–373

    PubMed  PubMed Central  Google Scholar 

  30. Nadalin S, Giacometti J, Buretić-Tomljanović A (2014) PPARα-L162V polymorphism is not associated with schizophrenia risk in a Croatian population. Prostaglandins Leukot Essent Fat Acids 91:221–225

    Article  CAS  Google Scholar 

  31. Norton N et al (2005) No evidence for association between polymorphism in GRM3 and schizophrenia. BMC Psychiatry 5:1–6

    Article  CAS  Google Scholar 

  32. Ozsoy F, Balcı N, Yigit S, Kulu M (2020) Effect of AUTS2 gene rs6943555 variant in male patients with schizophrenia in a Turkish population. Gene 756:144913

    Article  CAS  PubMed  Google Scholar 

  33. Pae CU et al (2009) Dysbindin gene (DTNBP1) and schizophrenia in Korean population. Eur Arch Psychiatry Clin Neurosci 259:137–142

    Article  PubMed  Google Scholar 

  34. Philibert R et al (2006) No association of the C677T methylenetetrahydrofolate reductase polymorphism with schizophrenia. Psychiatr Genet 16:221–223

    Article  PubMed  Google Scholar 

  35. Raffa M et al (2013) Relationship between GSTM1 and GSTT1 polymorphisms and schizophrenia: a case-control study in a Tunisian population. Gene 512:282–285

    Article  CAS  PubMed  Google Scholar 

  36. Ren D et al (2017) No association of GRIK4 polymorphisms with schizophrenia in the Chinese Han population. Psychiatr Genet 27:159–160

    Article  CAS  PubMed  Google Scholar 

  37. Zhang S et al (2018) Association between polymorphisms of the complement 3 gene and schizophrenia in a Han Chinese Population. Cell Physiol Biochem 46:2480–2486

    Article  CAS  PubMed  Google Scholar 

  38. Taghipour N, Saadat I, Saadat M (2019) Association between polymorphisms of Xeroderma pigmentosum complementation group C gene (XPC) and susceptibility to schizophrenia. Gene 695:99–100

    Article  CAS  PubMed  Google Scholar 

  39. Zhang X cen et al (2019) No association between polymorphisms in the promoter region of dopamine receptor D2 gene and schizophrenia in the northern Chinese Han population: a case–control study. Brain Behav 9:1–8

  40. Yang B et al (2017) Association study of the GLRX5 rs1007814 polymorphism with schizophrenia in the Han Chinese population. Psychiatr Genet 27:76–77

    Article  CAS  PubMed  Google Scholar 

  41. Yenilmez C et al (2017) A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes. J Clin Pharm Ther 42:103–107

    Article  CAS  PubMed  Google Scholar 

  42. Yue W et al (2011) A case-control association study of NRXN1 polymorphisms with schizophrenia in Chinese Han population. Behav Brain Funct 7:3–8

    Article  CAS  Google Scholar 

  43. Kucukali CI et al (2010) Angiotensin-converting enzyme polymorphism in schizophrenia, bipolar disorders, and their first-degree relatives. Psychiatr Genet 20:14–19

    Article  PubMed  Google Scholar 

  44. Crescenti A et al (2009) Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is associated with schizophrenia in a Spanish population. Psychiatry Res 165:175–180

    Article  CAS  PubMed  Google Scholar 

  45. Nsaiba MJ et al (2015) C3 Polymorphism influences circulating levels of C3, ASP and lipids in schizophrenic patients. Neurochem Res 40:906–914

    Article  CAS  PubMed  Google Scholar 

  46. Sória L dos S, Gubert C de M, Ceresér KM, Gama CS, Kapczinski F (2012) O aumento dos níveis séricos de C3 e C4 em pacientes com esquizofrenia em comparação com pacientes com transtorno bipolar eutímico e saudáveis. Rev Bras Psiquiatr 34, 119–120

  47. Parsons MJ et al (2007) A dopamine D2 receptor gene-related polymorphism is associated with schizophrenia in a Spanish population isolate. Psychiatr Genet 17:159–163

    Article  PubMed  Google Scholar 

  48. Cordeiro Q, Siqueira-Roberto J, Zung S, Vallada H (2009) Association between the DRD2-141C insertion/deletion polymorphism and schizophrenia. Arq Neuropsiquiatr 67:191–194

    Article  PubMed  Google Scholar 

  49. Tochigi M et al (2006) No association between the metabotropic glutamate receptor type 3 gene (GRM3) and schizophrenia in a Japanese population. Schizophr Res 88:260–264

    Article  PubMed  Google Scholar 

  50. Fujii Y et al (2003) Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia. Psychiatr Genet 13:71–76

    PubMed  Google Scholar 

  51. Saini SM et al (2017) Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk. Transl Psychiatry 7:e1196

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Wen Z et al (2016) Genetic association between NRG1 and schizophrenia, major depressive disorder, bipolar disorder in Han Chinese population. Am J Med Genet Part B Neuropsychiatr Genet 171:468–478

    Article  CAS  Google Scholar 

  53. Shiota S et al (2008) Association and interaction analyses of NRG1 and ERBB4 genes with schizophrenia in a Japanese population. J Hum Genet 53:929–935

    Article  PubMed  Google Scholar 

  54. Feng Y et al (2016) Association of PDE4B polymorphisms with susceptibility to schizophrenia: A meta-analysis of case-control studies. PLoS ONE 11:1–14

    Google Scholar 

  55. Ovadia G, Shifman S (2011) The genetic variation of RELN expression in schizophrenia and bipolar disorder. PLoS ONE 6:5

    Article  CAS  Google Scholar 

  56. Sozuguzel MD, Sazci A, Yildiz M (2019) Female gender specific association of the Reelin (RELN) gene rs7341475 variant with schizophrenia. Mol Biol Rep 46:3411–3416

    Article  CAS  PubMed  Google Scholar 

  57. Mohamed ZI et al (2019) Functional characterization of two variants in the 3’-untranslated region (UTR) of transcription factor 4 gene and their association with schizophrenia in sib-pairs from multiplex families. Asian J Psychiatr 40:76–81

    Article  PubMed  Google Scholar 

  58. Hui L et al (2015) TCF4 gene polymorphism is associated with cognition in patients with schizophrenia and healthy controls. J Psychiatr Res 69:95–101

    Article  PubMed  Google Scholar 

  59. Tesli M et al (2016) VRK2 gene expression in schizophrenia, bipolar disorder and healthy controls. Br J Psychiatry 209:114–120

    Article  PubMed  Google Scholar 

  60. Chang H et al (2016) Further evidence of VRK2 rs2312147 associated with schizophrenia. World J Biol Psychiatry 17:457–466

    Article  PubMed  Google Scholar 

Download references


Not applicable.


No funding was received for the present systematic review.

Author information

Authors and Affiliations



HB and AR designed research; FG, HB and AHO conducted the bibliographic research and selected the studies involved in this systematic review under the supervision of HB and AR; FG, HB and AHO performed the data extraction, assessment, and synthesis; FG, HB and AHO wrote the paper under the supervision of HB and AR; HB and AR had primary responsibility for final content. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Houssam Boulenouar.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Boulenouar, H., Benhatchi, H., Guermoudi, F. et al. An actualized screening of schizophrenia-associated genes. Egypt J Med Hum Genet 23, 81 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: